Maryam Kadivar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maryam Kadivar has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Azadeh Joulaee
Mahdieh Women's Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran
2 shared publicationsMojgan Kalantari
Breast Unit, Mahdieh Women's Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran
2 shared publications- Perikala Vijayananda Kumar
Department of Pathology Shiraz University of Medical Sciences Shiraz Iran
2 shared publications A. Hosseini
Department of Pathology, Iran University of Medical Sciences, Tehran, Iran
1 shared publicationAlireza Sadeghipour
Department of Pathology, Iran University of Medical Sciences, Tehran
1 shared publicationHomayoun Hadizadeh Kharazi
Radiology, and
1 shared publication
Latest Publications
- 20 September 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (27) , 81
Breast cancer patients' rights: How can they be respected in Iran?
81 Background: The revolutionary concept in breast cancer diagnosis and treatment has significantly changed many aspects of cancer treatment in favor of patients' rights. The best useful targeted treatment is offered to them with the least harm and invasion. As the most common cancer, breast cancer incidence is 24/100, 000 or one-fourth of all new cancers. The aim of this study is to compare the international rights for breast cancer patients with actual situation in Iran. Methods: All published data in Iran are reviewed since 2001 to 2012 to see the actual care in Iran. Codification of new radiology, surgical and pathologic procedure and insurance coverage are searched through available national references. These data are compared with international references. Results: Diagnosis is done by excisional/incisional biopsy or frozen section. Trucut biopsy is done in a low minority of cases. Insurance system does not cover vacuum assisted biopsy. Only mastectomy and axillary dissection are accepted by insurance. No codification exists for conservative surgery, oncoplastic surgery and sentinel node biopsy and the rate for these surgeries are low. Breast reconstruction, conservative surgery as bilateral mammoreduction, and symmetrization of controlateral breast are considered as cosmetic surgery with no coverage. The majority of cases are treated in general surgical wards. There are very few breast nurses and few centers for rehabilitation, lymphedema treatment, and psychological support of survivor. Conclusions: The ministry of health insists on full respection of the patient’s rights in medical practice. The new rights of breast cancer patients based on new treatment strategy are not highlighted in Iran. Valid evidence must be provided for policy makers about the rights of these vulnerable patients to consider them in Iranian health care delivery system. Specialized breast unit can improve significantly the quality of breast cancer care toward the patients' right. Pre-operative confirmation of cancer by trucut biopsy seems to be the key point. This gives the patient the opportunity to know more about the disease and to search for the best therapeutic plan according to international guideline.
- 20 September 2012
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (27) , 81
Breast cancer patients' rights: How can they be respected in Iran?
81 Background: The revolutionary concept in breast cancer diagnosis and treatment has significantly changed many aspects of cancer treatment in favor of patients' rights. The best useful targeted treatment is offered to them with the least harm and invasion. As the most common cancer, breast cancer incidence is 24/100, 000 or one-fourth of all new cancers. The aim of this study is to compare the international rights for breast cancer patients with actual situation in Iran. Methods: All published data in Iran are reviewed since 2001 to 2012 to see the actual care in Iran. Codification of new radiology, surgical and pathologic procedure and insurance coverage are searched through available national references. These data are compared with international references. Results: Diagnosis is done by excisional/incisional biopsy or frozen section. Trucut biopsy is done in a low minority of cases. Insurance system does not cover vacuum assisted biopsy. Only mastectomy and axillary dissection are accepted by insurance. No codification exists for conservative surgery, oncoplastic surgery and sentinel node biopsy and the rate for these surgeries are low. Breast reconstruction, conservative surgery as bilateral mammoreduction, and symmetrization of controlateral breast are considered as cosmetic surgery with no coverage. The majority of cases are treated in general surgical wards. There are very few breast nurses and few centers for rehabilitation, lymphedema treatment, and psychological support of survivor. Conclusions: The ministry of health insists on full respection of the patient’s rights in medical practice. The new rights of breast cancer patients based on new treatment strategy are not highlighted in Iran. Valid evidence must be provided for policy makers about the rights of these vulnerable patients to consider them in Iranian health care delivery system. Specialized breast unit can improve significantly the quality of breast cancer care toward the patients' right. Pre-operative confirmation of cancer by trucut biopsy seems to be the key point. This gives the patient the opportunity to know more about the disease and to search for the best therapeutic plan according to international guideline.
- 1 October 2008
- Vol. 30 (5)
Argyrophilic nucleolar organizer region counts in exfoliative cytology of buccal mucosa from opium addicts, smokers and nonsmokers.
To compare the argyrophilic nucleolar organizer region (AgNOR) count of cells collected from the normal buccal mucosa of cigarette smokers, opium addicts and nonsmokers.
- 1 October 2008
- Vol. 30 (5)
Argyrophilic nucleolar organizer region counts in exfoliative cytology of buccal mucosa from opium addicts, smokers and nonsmokers.
To compare the argyrophilic nucleolar organizer region (AgNOR) count of cells collected from the normal buccal mucosa of cigarette smokers, opium addicts and nonsmokers.
- Open Access
- 1 October 2007
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 86 (10) , 628-630
Osteoclast-Like Giant-Cell Tumor of the Parotid with Salivary Duct Carcinoma: Case Report and Cytologic, Histologic, and Immunohistochemical Findings
Primary giant-cell tumor of the salivary gland is a rare lesion with an incompletely characterized histogenesis. To the best of our knowledge, only 16 cases have been previously documented in the English-language literature. We report a new case, which occurred in a 75-year-old man who presented with a parotid mass and cervical lymphadenopathy. The patient underwent a left total parotidectomy and cervical lymph node dissection. As far as we know, ours is the only reported case of a primary giant-cell tumor of the salivary gland in which the patient presented with lymph node metastasis. Because so little is known about giant-cell tumor of the salivary gland, we use the occasion of this case report to describe the cytologic, histologic, and immunohistochemical characteristics that we observed.
- 1 October 2007
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 86 (10) , 628-630
Open AccessOsteoclast-Like Giant-Cell Tumor of the Parotid with Salivary Duct Carcinoma: Case Report and Cytologic, Histologic, and Immunohistochemical Findings
Primary giant-cell tumor of the salivary gland is a rare lesion with an incompletely characterized histogenesis. To the best of our knowledge, only 16 cases have been previously documented in the English-language literature. We report a new case, which occurred in a 75-year-old man who presented with a parotid mass and cervical lymphadenopathy. The patient underwent a left total parotidectomy and cervical lymph node dissection. As far as we know, ours is the only reported case of a primary giant-cell tumor of the salivary gland in which the patient presented with lymph node metastasis. Because so little is known about giant-cell tumor of the salivary gland, we use the occasion of this case report to describe the cytologic, histologic, and immunohistochemical characteristics that we observed.
- 1 March 2007
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 10 (2) , 138-141
Sialolipoma of the Parotid Gland with Diffuse Sebaceous Differentiation in a Female Child
Sialolipoma of the salivary gland is a tumor with ambiguous histogenesis. Histologically, this lesion is composed of mature adipose tissue and salivary glandular components. To the best of our knowledge, only 12 documented cases of sialolipoma have been reported in the literature. Except for 1 congenital case, all of the cases were found in adult patients. In this report, we present a unique case of sialolipoma with diffuse sebaceous differentiation in a 3-year-old female child. The differential diagnoses are discussed.
- 1 March 2007
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 10 (2) , 138-141
Sialolipoma of the Parotid Gland with Diffuse Sebaceous Differentiation in a Female Child
Sialolipoma of the salivary gland is a tumor with ambiguous histogenesis. Histologically, this lesion is composed of mature adipose tissue and salivary glandular components. To the best of our knowledge, only 12 documented cases of sialolipoma have been reported in the literature. Except for 1 congenital case, all of the cases were found in adult patients. In this report, we present a unique case of sialolipoma with diffuse sebaceous differentiation in a 3-year-old female child. The differential diagnoses are discussed.
- 25 January 2007
- Published by Wiley in Cytopathology
- Vol. 19 (1) , 61-62
Cytological findings of intrauterine and cervical choriocarcinoma
- 25 January 2007
- Published by Wiley in Cytopathology
- Vol. 19 (1) , 61-62
Cytological findings of intrauterine and cervical choriocarcinoma
- 1 October 2006
- Published by Wiley in Cytopathology
- Vol. 17 (5) , 310-312
Cytological findings of a primitive neuroectodermal tumour presenting as a parotid mass
- 1 October 2006
- Published by Wiley in Cytopathology
- Vol. 17 (5) , 310-312
Cytological findings of a primitive neuroectodermal tumour presenting as a parotid mass
- 1 January 2006
- Published by Hindawi Limited in The Breast Journal
- Vol. 12 (1) , 75-76
Orbital Metastasis as the First Presentation of Nonpalpable Invasive Lobular Carcinoma of the Breast
- 1 January 2006
- Published by Hindawi Limited in The Breast Journal
- Vol. 12 (1) , 75-76
Orbital Metastasis as the First Presentation of Nonpalpable Invasive Lobular Carcinoma of the Breast